Long non-coding RNAs as novel players in β cell function and type 1 diabetes

Area of Science:

• Molecular Biology
• Immunology
• Endocrinology

Background:

• Long non-coding RNAs (lncRNAs) are key regulators of gene expression.
• lncRNAs play critical roles in various pathophysiological conditions, including autoimmune and inflammatory diseases.
• Emerging evidence implicates lncRNAs in the pathogenesis of type 1 diabetes (T1D).

Purpose of the Study:

• To review the emerging roles of lncRNAs in immune and islet beta cell function.
• To discuss the challenges and opportunities in understanding T1D pathogenesis and complications.
• To highlight lncRNAs as potential therapeutic targets in T1D.

Main Methods:

• Literature review of studies on lncRNAs in T1D.
• Analysis of lncRNA interactions with RNA, DNA, and proteins.
• Examination of lncRNA involvement in immune and beta cell biology.

Main Results:

• lncRNAs are versatile regulators involved in diverse cellular processes.
• lncRNAs contribute to the immune dysregulation observed in T1D.
• lncRNAs influence islet beta cell function and survival.

Conclusions:

• lncRNAs within T1D-loci regions, along with regulatory variants and enhancers, remodel chromatin.
• These lncRNAs act as cis/trans-regulatory determinants of islet cell transcriptional programs.
• lncRNAs represent a promising area for T1D research and therapeutic development.